BTLA Antikörper
Kurzübersicht für BTLA Antikörper (ABIN1496981)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human BTLA
-
Aufreinigung
- Protein A/G purified
-
Immunogen
-
Full length human recombinant protein of human BTLA(NP_861445) produced in HEK293T cell.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Approved: IF (1:100), IHC, IHC-P (1:150), WB (1:2000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA / CD272
-
Hintergrund
-
Name/Gene ID: BTLA
Synonyms: BTLA, BTLA1, B and T lymphocyte associated, CD272, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, CD272 antigen -
Gen-ID
- 151888
-
NCBI Accession
- NP_861445
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-